Showing results (621-630 of 637) with videos related to
Sort By:
Pageof 64
Science Advances|March 20, 2021
Massive clonal expansion of polycytotoxic skin and blood CD8<sup>+</sup> T cells in patients with toxic epidermal necrolysisAxel Patrice Villani, Aurore Rozieres, Benoît Bensaid, et al.Journal of Molecular Cell Biology|October 14, 2015
Atad2 is a generalist facilitator of chromatin dynamics in embryonic stem cellsYuichi Morozumi, Fayçal Boussouar, Minjia Tan, et al.Gut|February 12, 2015
Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cureMirjam B Zeisel, Julie Lucifora, William S Mason, et al.Cell Death & Disease|September 25, 2023
Identification of a miRNA multi-targeting therapeutic strategy in glioblastomaArthur Bassot, Helena Dragic, Sarah Al Haddad, et al.Nature|October 21, 2021
Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccinationBruno Pozzetto, Vincent Legros, Sophia Djebali, et al.Journal of Hepatology|January 26, 2023
Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanismsJulie Lucifora, Dulce Alfaiate, Caroline Pons, et al.Advanced Materials (Deerfield Beach, Fla.)|September 9, 2021
Spin-Charge Interconversion in KTaO<sub>3</sub> 2D Electron GasesLuis M Vicente-Arche, Julien Bréhin, Sara Varotto, et al.Elife|October 7, 2024
BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomasPaul Huchede, Swann Meyer, Clément Berthelot, et al.Nature Medicine|April 26, 2011
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapyJoachim Lupberger, Mirjam B Zeisel, Fei Xiao, et al.Genes|August 27, 2021
An Integrated Clinical-Biological Approach to Identify Interindividual Variability and Atypical Phenotype-Genotype Correlations in Myopathies: Experience on A Cohort of 156 FamiliesRaul Juntas Morales, Aurélien Perrin, Guilhem Solé, et al.Pageof 64